Spectrum of single‐ and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients

Neurofibromatosis type 1 (NF1), the most common tumor‐predisposing disorder in humans, is caused by defects in the NF1 tumor‐suppressor gene. Comprehensive mutation analysis applying RNA‐based techniques complemented with FISH analysis achieves mutation detection rates of ∼95% in NF1 patients. The majority of mutations are minor lesions, and ∼5% are total gene deletions. We found 13 single‐ and/or multiexon deletions/duplications out of 1,050 detected mutations using our RNA‐based approach in a cohort of 1,100 NF1 patients and confirmed these changes using multiplex ligation‐dependent probe amplification (MLPA). With MLPA, we found another 12 novel multiexon deletion/duplications in 55 NF1 patients for whom analysis with multiple assays had not revealed a NF1 mutation, including 50 previously analyzed comprehensively. The extent of the 22 deletions and 3 duplications varied greatly, and there was no clustering of breakpoints. We also evaluated the sensitivity of MLPA in identifying deletions in a mosaic state. Furthermore, we tested whether the MLPA P122 NF1 area assay could distinguish between type I deletions, with breakpoints in low‐copy repeats (NF1‐LCRs), and type II deletions, caused by aberrant recombination between the JJAZ gene and its pseudogene. Our study showed that intragenic deletions and/or duplications represent only ∼2% of all NF1 mutations. Although MLPA did not substantially increase the mutation detection rate in NF1 patients, it was a useful first step in a comprehensive mutation analysis scheme to quickly pinpoint patients with single‐ or multiexon deletions/duplications as well as patients with a total gene deletion who will not need full sequencing of the complete coding region. © 2005 Wiley‐Liss, Inc.

[1]  L. Messiaen,et al.  Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1. , 2005, Journal of medical genetics.

[2]  M. Tatagiba,et al.  Screening for large mutations of the NF2 gene , 2005, Genes, chromosomes & cancer.

[3]  J. Vermeesch,et al.  Large deletions of the APC gene in 15% of mutation‐negative patients with classical polyposis (FAP): A Belgian study , 2005, Human mutation.

[4]  X. Estivill,et al.  A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene , 1993, Human Genetics.

[5]  P. Chappuis,et al.  Significant Contribution of Germline BRCA2 Rearrangements in Male Breast Cancer Families , 2004, Cancer Research.

[6]  H. Kehrer-Sawatzki,et al.  High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. , 2004, American journal of human genetics.

[7]  R. Siebert,et al.  Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene , 2004, Human mutation.

[8]  X. Estivill,et al.  Two CA/GT repeat polymorphisms in intron 27 of the human neurofibromatosis type 1 (NF1) gene , 1994, Human Genetics.

[9]  I. Vandenbroucke,et al.  Genetic and clinical mosaicism in a patient with neurofibromatosis type 1 , 2004, Human Genetics.

[10]  G. Taylor,et al.  Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non‐polyposis colorectal cancer: Identification of novel and recurrent deletions by MLPA , 2003, Human mutation.

[11]  H. Nakagawa,et al.  Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques , 2003, Human mutation.

[12]  L. V. van't Veer,et al.  Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. , 2003, Cancer research.

[13]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[14]  H. Hameister,et al.  Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. , 2001, American journal of human genetics.

[15]  M. Dorschner,et al.  Recombination hotspot in NF1 microdeletion patients. , 2001, Human molecular genetics.

[16]  G Mortier,et al.  Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.

[17]  D. Horn,et al.  A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions. , 2000, Genomics.

[18]  K. Wimmer,et al.  Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients , 2000, Human Genetics.

[19]  M. Weaver,et al.  NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. , 2000, Human molecular genetics.

[20]  X. Estivill,et al.  Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions , 1999, Human mutation.

[21]  J. Friedman,et al.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. , 1997, American journal of medical genetics.

[22]  R. Heim,et al.  Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. , 1995, Human molecular genetics.

[23]  D. Bell,et al.  Extended-term cultures of human T-lymphocytes: a practical alternative to primary human lymphocytes for use in genotoxicity testing. , 1995, Mutagenesis.

[24]  A. Paller.  Neurofibromatosis: Phenotype, Natural History, and Pathogenesis , 1993 .

[25]  B. Cohen.  Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 2nd Ed. , 1992 .

[26]  P. O'Connell,et al.  An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1) , 1991, Nucleic Acids Res..

[27]  P. O'Connell,et al.  Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. , 1990, Genomics.

[28]  B. Brownstein,et al.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.

[29]  P. O'Connell,et al.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus , 1990, Cell.